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of-use#LAAJournal of Biomedical Research ， 2010  ， 24(1):2-5 JBR Mini Review www.jbr - pub.org * Corresponding author E - mail address:  zhigang.he@childrens.harvard.edu Two types of axon re - growth for functional  recovery after CNS injury. Injury to the mammalian adult central nervous  Abstract Spinal cord injury disrupts the connections between the brain and spinal cord, often resulting in the loss of  sensory and motor function below the lesion site. The most important reason for such permanent functional  deficits is the failure of injured axons to regenerate after injury. In principle, the functional recovery could be  achieved by two forms of axonal regrowth: the regeneration of lesioned axons which will reconnect with their  original targets and the sprouting of spared axons that form new circuits and compensate for the lost function.  Our recent studies reveal the activity of the mammalian target of rapamycin (mTOR) pathway, a major regulator  of new protein synthesis, as a critical determinant of axon regrowth in the adult retinal ganglion neurons [1] . In this  review, I summarize current understanding of the cellular and molecular mechanisms that control the intrinsic  regenerative ability of mature neurons. Intrinsic control of axon regeneration  Zhigang He * F.M. Kirby Neurobiology Center, Children ' s Hospital, and Department of Neurology,  Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. Received 25 December 2009 Zhigang He, who is an associate professor in department  of neurology of Harvard Medical School, is interested in why  lesioned axons cannot regenerate in the adult mammalian central  nervous system (CNS). Recent studies from He's laboratory and  others suggested that three myelin proteins , myelin - associated  glycoprotein (MAG), Nogo - A and oligodendrocyte myelin  glycoprotein (OMgp) , collectively account for the majority of  the inhibitory activity in CNS myelin. The inhibitory activity  of MAG, OMgp and the extracellular domain of Nogo - A might  be mediated by a receptor complex with a Nogo receptor and at  least two co - receptors, p75/TROY and Lingo - 1. Blocking such  inhibitory activity by genetic and pharmacological approaches  could promote local axonal sprouting and reactivate structural  plasticity but is not sufficient to allow long - distance axon  regeneration. His current studies are aimed to define cellular  and molecular mechanisms underlying the intrinsic regenerative  capacity of mature neurons. He and his colleagues envision two  main possibilities for the lack of axon regrowth responses after  an injury:  ①  the signals carrying information of axotomy fail to  reach to the cell body for activating regenerative program; and/ or  ②  the axonal growth program could not to be reactivated  even if the retrograde signals are delivered to the cell bodies.  They are addressing these issues by a combination of  in vitro  and  in vivo  approaches.3 　 Z.He et al. / Journal of Biomedical Research, 2010, 24(1): 2-5 system (CNS) often results in functional deficits,  largely owing to the limited regenerative and repairing  capabilities. In the case of spinal cord injury, the  disruption of axonal tracts that convey ascending  sensory and descending motor information could  lead to pronounced and persistent sensorimotor  dysfunctions in the body parts below the lesion sites.  Although partial spontaneous functional recovery  occurs in the patients and animal models at the  neonatal stages, this declines in the adult. Presumably,  rebuilding the functional circuits may result from two  types of axon regrowth:  ①  true regenerative growth  of injured axons and  ②  compensatory sprouting from  spared fibers. While regenerative growth occurs rarely  in the adult CNS, compensatory sprouting of the same  or different types of axons may form new circuits  across the lesion sites and compensate for the function  lost as the result of injury. Thus, ideal repair strategies  could be to promote these two different forms of axon  regrowth for optimal functional recovery.  Importance of the loss of intrinsic growth  ability in regeneration failure In contrast to robust axon growth during  development, both regenerative growth and  compensatory sprouting in the adult CNS are very  limited and abortive. Many studies in the past  decades have been largely focused on characterizing  environmental inhibitory molecules in the adult  CNS [2 - 7] . Several myelin associated molecules and  chondroitin sulfate proteoglycans (CSPGs) in the  glial scar have been implicated as inhibitors of axon  regeneration [2 - 7] . A few critical signaling molecules  mediating these inhibitory activities have also been  identified. However, when blocking such inhibitory  activities by either genetic or pharmacological  means, only limited axon regeneration is observed  in experimental spinal cord injury models [3,6,7] .  Furthermore, despite demonstrations that some injured  axons are able to regrow into the permissive grafts, the  majority of adult neurons fail to regenerate axons when  provided with permissive substrate [8] . Together, these  studies suggest that removing inhibitory activities is  not sufficient to allow the majority of injured CNS  axons to regenerate, pointing to the importance of  understanding the mechanisms controlling the intrinsic  axon growth/regenerative abilities of neurons.  Growth factor - dependent axon growth during  development A potentially useful approach to understand the  intrinsic mechanisms of axon regeneration is to study  how robust axon growth in immature neurons during  development is achieved. Many of these studies  involve neurotrophin - dependent axon growth of  peripheral neurons. For example, by using specific  chemical inhibitors, Liu and Snider [9]  showed that  nerve growth facton (NGF) - dependent axon growth  from E13 sensory neurons require the activation of Erk  kinase (MEK) - extracellular signal - regulated kinase  (ERK), phosphatidylinositol - 3 kinase (PI3 - K), but  not janus kinase (JAK) signaling. Interestingly, these  pathways mediate distinct aspects of axon growth.  For example, activated Raf - 1 causes axon lengthening  comparable to NGF, while active Akt increases axon  caliber and branching [10] . In the case of CNS neurons,  previous work suggests that peptide - based growth  factors are clearly important for stimulating rapid  axon growth, although they may not be sufficient.  For example, Ben Barres ’  lab demonstrated that the  combination of neuronal activity (or cAMP) and  growth factors is needed to promote the survival and  axon growth of cultured retinal ganglion neurons  (RGCs) [11] . Recent studies showed that insulin - like  grawth factor (IGF) could promote axon growth  from cultured corticospinal motor neurons (CSMNs)  purified from young animals [12] . Thus, it appears  that for both peripheral nervous system (PNS) and  CNS neurons, responses to neurotrophins and other  growth factors are critical for axon growth during  development.  Mechanisms for development - dependent  decrease of axon growth ability Despite the progress made in axon growth during  development, little is known about what accounts for  the transition from the rapid growth mode of immature  neurons into the poor growth mode of mature neurons  in the CNS. Several potential players have been  implicated, such as development - dependent decline of  neuronal cAMP levels [13] , or Bcl - 2 [14] . By analyzing the  axon growth rates of RGCs, Goldberg et al [15]  found a  dramatic decrease occurring at the neonatal stage and  this might be triggered by signal(s) from amacrine  cells. However, the molecular nature of such signal(s)  still remains elusive. In addition, anaphase promoting  complex (APC), a protein complex with E3 ubiquitin  ligase having a well - documented function in cell cycle  control, has been recently implicated in controlling  axon growth ability [16] . Some experimental evidence  implicated that the APC activity remains active in  post - mitotic neurons, and it may degrade proteins  required for axon growth, such as the transcription  factors ID2 and SnoN [17,18] . However, whether these  molecules are relevant to the axon regenerative ability  in vivo  is unclear. 　 4 Z.He et al. / Journal of Biomedical Research, 2010, 24(1): 2-5 Phosphatase and tensin homolog/rapamycin  (PTEN/mTOR) pathway in axon growth  control Development - dependent decline of axon growth  ability is reminiscent of cell size control in almost any  cell type: active growth during development followed  by ceased growth upon the completion of development  result in a normally fixed size for individual cell  types. Extensive studies in the fields of developmental  biology and cancer biology have identified a number  of genes critical for regulating cellular growth and many  of these are tumor suppressor genes. Because many of  these growth - control molecules are expressed in the  adult neurons, we hypothesized that the mechanisms  preventing individual cell types from over - growth might  also play a role in suppressing the axon growth ability of  adult neurons. To test this, we utilized an optic nerve  crush model to examine the regeneration of axons  from RGCs in different mutant mice with the deletion  of individual growth control genes in the RGCs. By  analyzing more than 10 different conditional deletion  mouse lines, we found that deletion of PTEN promotes  both the survival of axotomized RGCs and the robust  regeneration of injured optic nerve fibers [1] . PTEN is  a critical intracellular regulator of cellular responses  References: [1]    Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et  al. Promoting axon regeneration in the adult CNS by  Fig.1   Scheme of the PTEN/mTOR signaling pathway. In response to receptor tyrosine kinase (RTK) activation, PI3K phosphorylates  and converts the lipid second messenger PIP 2  into PIP 3 , which recruits and activates phosphatidylinositol - dependent kinase 1/2  (PDK1/2). PDK1/2, in turn, phosphorylates and activates Akt. PTEN catalyzes the conversion from PIP 3  to PIP 2 . Thus, inactivation  of PTEN results in the accumulation of PIP 3  and the activation of Akt. Akt controls a host of signaling molecules, including TSC1/2.  Downstream of the TSC1/2 complex lies mTOR, which integrates various cellular signals, including nutrient availability to control  protein translation, cell growth, and other processes. The ribosomal protein S6 kinase (RP - S6) and the eukaryotic initiation factor 4E  (eIF - 4E) binding protein 1 (4E - BP1) are the mTOR effector molecules executing these functions. Cellular stresses such as hypoxia  induce expression of Redd1/2, which augments TSC1/2 activity and in turn suppress the mTOR activity. Stress(eg. hypoxia) RTK Redd1/2 PDK1/2 AKT       GSK - 3 TSC1 TSC2 mTOR 4E - BP1 eIF - 4E Protein synthesis Cell growth S6K1 S6 PI3K PTEN PIP2 PIP3 to growth factors ( Fig. 1 , ref. 19 - 21). It catalyzes the  conversion from  phosphatidylinositol (3,4,5) trisphosphate  ( PIP 3 ) to  phosphatidylinositol (4,5) bisphosphate ( PIP 2 ) and  antagonizes the effects of PI3K. Thus, inactivation  of PTEN results in the accumulation of PIP 3  and  subsequently the activation of the Akt. A well  characterized downstream event of PTEN deletion and  Akt activation is the activation of mTOR, which is a  central regulator of cap - dependent protein translation  initiation and cell growth [19 - 21] . Thus, it is possible  that PTEN deletion results in enhanced mTOR  activity and new protein synthesis which may sustain  axon regrowth for regeneration. Importantly, our  studies revealed that mTOR activity is significantly  down - regulated in injured CNS neurons, but not in  PNS neurons [1] . Thus, the lack of mTOR activity  may represent a major intrinsic obstacle for axon  regeneration in injured CNS neurons. These studies  strongly support the hypothesis that the activity of  the PTEN/mTOR pathway is a key determinant of the  intrinsic axon growth ability of adult CNS neurons. It  will be important to assess whether manipulating this  pathway could promote axon regeneration from other  types of CNS neurons and whether these regenerating  axons are able to form functional synapses.  modulation of the PTEN/mTOR pathway.  Science  2008;  322:963 - 6. [2]   Busch SA, Silver J. The role of extracellular matrix in 5 　 Z.He et al. / Journal of Biomedical Research, 2010, 24(1): 2-5 CNS regeneration.  Curr Opin Neurobiol  2007; 17:120 - 7. [3]    Case LC, Tessier - Lavigne M. Regeneration of the adult  central nervous system.  Curr Biol  2005;15:R749 - 53. [4]    Filbin MT. Recapitulate development to promote axonal  regeneration: good or bad approach?  Philos Trans R Soc  Lond B Biol Sci  2006;361:1565 - 74. [5]   Cafferty WB, McGee AW, Strittmatter SM. Axonal  growth therapeutics: regeneration or sprouting or  plasticity?  Trends Neurosci  2008;31:215 - 20. [6]    Blesch A, Tuszynski MH. Spinal cord injury: plasticity,  regeneration and the challenge of translational drug  development.  Trends Neurosci  2009;32:41 - 7. [7]     Yiu G, He Z. Glial inhibition of CNS axon regeneration.  Nat  Rev Neurosci  2006;7:617 - 27. [8]   Aguayo AJ, Rasminsky M, Bray GM, Carbonetto S,  McKerracher L, Villegas - P é rez MP, et al. Degenerative  and regenerative responses of injured neurons in the  central nervous system of adult mammals.  Philos Trans  R Soc Lond B Biol Sci  1991;331:337 - 43. [9]    Liu RY, Snider WD. Different signaling pathways mediate  regenerative versus developmental sensory axon growth.  J Neurosci  2001;21:RC164. [10]  Markus A, Zhong J, Snider WD. Raf and akt  mediate    distinct aspects of sensory axon growth.  Neuron   2002;35:65 - 76. [11]  Goldberg JL, Barres BA. The relationship between    neuronal survival and regeneration.  Annu Rev Neurosci    2000;23:579 - 612. [12]  Ozdinler PH, Macklis JD. IGF - I specifically enhances  axon outgrowth of corticospinal motor neurons.  Nat  Neurosci  2006;9:1371 - 81. [13]   Hannila SS, Filbin MT. The role of cyclic AMP signaling in  promoting axonal regeneration after spinal cord injury.  Exp Neurol.  2008;209:321 - 32. [14]   Jiao J, Huang X, Feit - Leithman RA, Neve RL, Snider  W, Dartt DA, et al. Bcl - 2 enhances Ca(2+) signaling to  support the intrinsic regenerative capacity of CNS axons.  EMBO J  2005;24:1068 - 78.  [15]  Goldberg JL, Klassen MP, Hua Y, Barres BA. Amacrine - signaled loss of intrinsic axon growth ability by retinal  ganglion cells.  Science  2002;296:1860 - 4. [16] Konishi Y, Stegm ü ller J, Matsuda T, Bonni S, Bonni A.  Cdh1 - APC controls axonal growth and patterning in the  mammalian brain.  Science  2004;303:1026 - 30. [17]  Lasorella A, Stegm ü ller J, Guardavaccaro D, Liu G,  Carro MS, Rothschild G, et al. Degradation of Id2 by the  anaphase - promoting complex couples cell cycle exit and  axonal growth.  Nature  2006;442:471 - 4. [18]  Stegm ü ller J, Konishi Y, Huynh MA, Yuan Z, Dibacco  S, Bonni A. Cell - intrinsic regulation of axonal  morphogenesis by the Cdh1 - APC target SnoN.  Neuron   2006;50:389 - 400. [19]   Guertin DA, Sabatini DM. An expanding role for mTOR  in cancer.  Trends Mol Med  2005;11:353 - 61. [20]  Hay N. The Akt - mTOR tango and its relevance to cancer.  Cancer Cell  2005;8:179 - 83. [21]  Tee AR, Blenis J. mTOR, translational control and human  disease.  Semin Cell Dev Biol  2005;16:29 - 37.